4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-16-017712
Chief Scientific Officer & EVP sold 61,000 shares at an average $26.16 ($1,595,586)
From the SEC's structured data for this filing
Trades in this filing
COOK DAVID N · Chief Scientific Officer & EVP
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-01 | Sale : show line 1 in the form | −46,650 | $25.74 | $1,200,771 | 183,023 | D |
| 2016-04-01 | Sale : show line 2 in the form | −6,350 | $26.90 | $170,815 | 176,673 | D |
| 2016-04-04 | Sale : show line 3 in the form | −8,000 | $28.00 | $224,000 | 168,673 | D |
| Open-market sales · 61,000 sh · avg $26.16 · $1,595,586 | ||||||
Loading xslF345X03/doc4.xml…